相关实验视频
Updated: Jan 17, 2026

16:11
Implantation of the Syncardia Total Artificial Heart
Published on: July 18, 2014
36.0K
在接受TAVR的患者中预测长期存活的因素:最近的进展. 一个叙事审查
Lior Zornitzki1,2, Jeremy Ben-Shoshan3,4
1Department of Cardiology, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel. lior.zoz@gmail.com.
Kardiologia polska
|September 24, 2025
概括
超导管大动脉置换 (TAVR) 正在演变为终身管理. 了解长期生存的预测因素对于个性化TAVR患者护理至关重要.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 老年心脏病学 老年心脏病学
背景情况:
- 过导管大动脉置换 (TAVR) 管理已经转向严重大动脉狭窄的终身策略.
- 识别超过五年的长期生存预测因素对于个性化TAVR治疗决策至关重要.
研究的目的:
- 审查目前关于TAVR后长期死亡率预测因素的证据.
- 突出影响TAVR结果的新型患者,程序和门相关因素.
主要方法:
- 这是一个叙述性综述,总结了现有的文学作品.
- 专注于与患者相关的因素,新型生物标志物,程序元素和门特征.
主要成果:
- 关键预测因素包括晚年,功能障碍,心室功能减弱 (例如GLS,RV-PA脱).
- 新兴的生物标志物 (GDF-15,克隆性血液形成标志物) 显示出预后价值.
- 程序因素 (访问,PVL,PPM) 和门选择 (SEV与BEV,超环形与环形) 影响结果.
结论:
- 整合多方面的预测因素对于定制TAVR设备选择至关重要.
- 优化TAVR结果需要采用综合方法,考虑各种患者和程序因素.
- 未来的研究应该专注于将这些预测因素结合起来,以实现持久的,个性化的TAVR管理.
相关概念视频
Cancer Survival Analysis
648
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
648
Survival Tree
388
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
Building a Survival Tree
Constructing a...
Building a Survival Tree
Constructing a...
388
Kaplan-Meier Approach
577
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
577
Actuarial Approach
288
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
288
Comparing the Survival Analysis of Two or More Groups
561
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
561
